文献速递痛风与晶体性关节病

血清脂质组学揭示无症状高尿酸血症与痛风患者的不同代谢谱

Serum lipidomics reveals distinct metabolic profiles for asymptomatic hyperuricemic and gout patients.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

本研究采用超高效液相色谱-四极杆静电场轨道阱质谱(UHPLC-Q Exactive MS)对来自两个中心的88名正常对照、157例无症状高尿酸血症(HUA)和183例痛风患者进行血清脂质组学分析。研究发现HUA与痛风之间存在116种差异代谢物,其中TAG 18:1-20:0-22:1和TAG 14:0-16:0-16:1组成的生物标志物组合在发现集中区分HUA与痛风的ROC曲线下面积为0.8288(95%CI 0.747, 0.9106),灵敏度82%,特异度78%,内部验证预测准确率74.38%,外部验证84.03%。

要点

  • HUA与痛风患者血清脂质代谢谱存在显著差异,涉及甘油二酯、甘油三酯、磷脂酰胆碱等。
  • TAG 18:1-20:0-22:1与TAG 14:0-16:0-16:1组合可较好区分HUA与痛风。
  • 该生物标志物组合在外部验证集中预测准确率达84.03%。

核心结论

  • 研究识别出具有预测和诊断HUA与痛风潜力的血清生物标志物组合。

研究设计与样本

  • 研究纳入中心1(南京中医药大学附属医院,发现集与内部验证集)和中心2(苏州市中医医院,外部验证集)共88名正常受试者、157例HUA和183例痛风患者,采用UHPLC-Q Exactive MS进行血清脂质组学分析。

主要发现

  • 发现集中正常 vs HUA有245种差异代谢物,正常 vs 痛风有150种差异代谢物,HUA vs 痛风有116种差异代谢物。
  • 差异代谢物包括甘油二酯、甘油三酯(TAG)、磷脂酰胆碱、磷脂酰乙醇胺、磷脂酰肌醇等。
  • TAG 18:1-20:0-22:1与TAG 14:0-16:0-16:1组合区分HUA与痛风的ROC曲线下面积为0.8288(95%CI 0.747, 0.9106),灵敏度82%,特异度78%。
  • 该组合在内部验证集中区分HUA与痛风的预测准确率为74.38%,外部验证集为84.03%。

关键数值与推荐

  • 差异代谢物筛选标准为正交偏最小二乘判别分析(OPLS-DA)模式下变量投影重要性(VIP)≥1且错误发现率校正P≤0.05。

临床怎么用

  • 血清脂质组学生物标志物组合(TAG 18:1-20:0-22:1和TAG 14:0-16:0-16:1)有望用于预测和区分无症状高尿酸血症与痛风。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to characterize the systemic lipid profile of patients with asymptomatic hyperuricemia (HUA) and gout using lipidomics, and to find potential underlying pathological mechanisms therefrom. METHODS: Sera were collected from Affiliated Hospital of Nanjing University of Chinese Medicine as centre 1 (discovery and internal validation sets) and Suzhou Hospital of Traditional Chinese Medicine as centre 2 (external validation set), including 88 normal subjects, 157 HUA and 183 gout patients. Lipidomics was performed by ultra high performance liquid chromatography plus Q-Exactive mass spectrometry (UHPLC-Q Exactive MS). Differential metabolites were identifed by both variable importance in the projection ≥1 in orthogonal partial least-squares discriminant analysis mode and false discovery rate adjusted P ≤ 0.05. Biomarkers were found by logistic regression and receiver operating characteristic (ROC) analysis. RESULTS: In the discovery set, a total of 245 and 150 metabolites, respectively, were found for normal subjects vs HUA and normal subjects vs gout. The disturbed metabolites included diacylglycerol, triacylglycerol (TAG), phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol, etc. We also found 116 differential metabolites for HUA vs gout. Among them, the biomarker panel of TAG 18:1-20:0-22:1 and TAG 14:0-16:0-16:1 could differentiate well between HUA and gout. The area under the receiver operating characteristic ROC curve was 0.8288, the sensitivity was 82% and the specificity was 78%, at a 95% CI 0.747, 0.9106. In the internal validation set, the predictive accuracy of TAG 18:1-20:0-22:1 and TAG 14:0-16:0-16:1 panel for differentiation of HUA and gout reached 74.38%, while it was 84.03% in external validation set. CONCLUSION: We identified serum biomarkers panel that have the potential to predict and diagnose HUA and gout patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Liu S, Wang Y, Liu H, et al. Serum lipidomics reveals distinct metabolic profiles for asymptomatic hyperuricemic and gout patients. Rheumatology (Oxford). 2022. PMID: 34599805. doi:10.1093/rheumatology/keab743

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。